Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection.

Laura Corbella Mario Fernández-Ruiz Maria Ruiz-Ruigomez Isabel Rodríguez-Goncer Jose Tiago Silva Pilar Hernández-Jimenez Francisco López-MedranoManuel LizasoainJennifer Villa Jose María Aguado Rafael San-Juan

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)

Our matched analysis suggests that the production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in K. pneumoniae infection as compared to episodes due to non-carbapenemase-producing strains.

Keyphrases

klebsiella pneumoniae
escherichia coli
multidrug resistant
acinetobacter baumannii
drug resistant
gram negative